Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type
2007-003210-33Phase 2Completed
- Sponsor
- Turku University Hospital
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ropinirole in Unverricht-Lundborg disease (ULD) and myoclonic epilepsies, sponsored by Turku University Hospital. Primary endpoint: Clinical efficacy and safety. Started Jun 2007; status: completed.
02
Drugs
ropinirole
03
Conditions
Unverricht-Lundborg disease (ULD)myoclonic epilepsies
Beyond the preview
Go deeper on 2007-003210-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003210-33.